NUVBNuvation Bio Inc.
6.930USD-4.55%Mkt Cap: 2.43B $P/E: —3d ago
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment. The company's lead product candidate is IBTROZI (taletrectinib), a ROS1 inhibitor for the trea…
Industry Peers
Biotechnology$138.82BUSDP/E 31.9
$85.87BUSDP/E 20.5
$61.34BUSDP/E 39.8
$65.05BUSDP/E 39.6
$57.94BUSD
$45.95BUSDP/E 19.6
$44.89BUSD
$42.36BUSDP/E 67.2
$35.43BUSDP/E 32.6
$31.61BUSDP/E 41.2
$29.28BUSD
$27.47BUSD
$26.22BUSD
$25.91BUSDP/E 16.2
$20.86BUSDP/E 26.3
$19.26BUSDP/E 26.6
$16.61BUSDP/E 19.6
$16.51BUSDP/E 17.4
$15.93BUSD
$13.40BUSDP/E 17.0
Key Statistics
Company
Market Cap2.43B $
Enterprise Value2.15B $
Revenue (TTM)169.90M $
Gross Profit53.60M $
Net Income (TTM)-204.63M $
Revenue/Share0.4970 USD
Last Price6.930 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees305
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-455.33
PEG—
EV/EBITDA-15.89
EV/Revenue12.67
P/S14.12
P/B9.41
EPS (TTM)-0.41
EPS (Forward)-0.01
52W Range
2.57061% of range9.750
52W High9.750 USD
52W Low2.570 USD
Profitability
Gross Margin85.22%
Oper. Margin-161.06%
EBITDA Margin-79.74%
Profit Margin-325.31%
ROE-66.93%
ROA-34.40%
Growth
Revenue Growth555.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-173.43M $
CapEx (TTM)8.35M $
FCF Margin-65.99%
FCF Yield-4.61%
Net Debt-244.69M $
Net Debt/EBITDA1.81
Balance Sheet
Debt/Equity0.19
Current Ratio8.37
Quick Ratio7.98
Book Value/Sh0.7260 USD
Cash/Share1.882 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.5 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)13.10 USD
Upside (mean)+89.0%
Target Range7.000 USD – 21.00 USD
$7.000+89.0% to mean$21.00
# Analysts10
Ownership
Shares Out.350.12M
Float263.65M
Insiders18.44%
Institutions67.90%
Short Interest
Short Ratio7.8d
Short % Float25.21%
Short % Out.15.27%
Shares Short53.42M
Short (prev mo.)54.36M
Technical
SMA 506.033 (+14.9%)
SMA 2005.847 (+18.5%)
Beta1.52
S&P 52W Chg18.16%
Avg Vol (30d)5.75M
Avg Vol (10d)6.48M
Technical Indicators
RSI (14)59.3
MACD0.2016
MACD Signal0.1765
MACD Hist.+0.0251
BB Upper7.055 USD
BB Middle6.497 USD
BB Lower5.939 USD
BB Width17.17%
ATR (14)0.4246 USD
Vol Ratio (20d)0.85x